Cargando…
Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report
BACKGROUND: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has been leading to dramatic health, social and economic problems around the world. It was necessary to introduce worldwide vaccination program against SARS-CoV-2 virus. Vaccination of billions of people around the...
Autores principales: | Gustavsen, Stefan, Nordling, Mette Maria, Weglewski, Arkadiusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828362/ https://www.ncbi.nlm.nih.gov/pubmed/36643729 http://dx.doi.org/10.1186/s42269-023-00981-7 |
Ejemplares similares
-
Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022) -
Acute disseminated encephalomyelitis with bilateral optic neuritis following ChAdOx1 COVID-19 vaccination
por: Nagaratnam, Sai A., et al.
Publicado: (2022) -
Acute disseminated encephalomyelitis following coronavirus disease vaccination
por: Pereira, Ronaldo Gonçalves, et al.
Publicado: (2022) -
Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: A case report
por: Lazaro, Luciana G., et al.
Publicado: (2022) -
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines
por: Yoneda, Makoto
Publicado: (2016)